Have any questions? 706-721-6582 or cts@augusta.edu
This is a research study to test a new drug called KRT-232 that is not approved by the Food and Drug Administration (FDA) to treat Chroic Myeloid Leukemia (CML). We are looking to see if the drug works on your cancer, if the drug is safe and what type of treatment is better. Prior to entry into this study, you will also need to be taking either nilotinib or dasatinib. The combination of KRT-232 with nilotinib or dasatinib is also investigational.